Dopamine levels drive the vigor of our movements, explaining why we move faster and with more energy when we are happy or ...
Proteins (evasin) from tick saliva could help treat multiple sclerosis and cancer by suppressing the inflammation and paving the way for new treatments.
Adding belzutifan to pembrolizumab after kidney cancer surgery cuts recurrence risk by 28%, helping high-risk patients stay ...
GLP-1 drugs like Ozempic and Mounjaro show no increased thyroid cancer risk in human data, despite lawsuits over stomach ...
Yale research redefines obesity as a chronic disease rather than a lack of willpower. New GLP-1 treatments and clinical ...
Study finds pigmented japonica rice like black and green varieties contain bioactive lipids and show slower starch digestion ...
Philips Unveils Rembra CT at ECR 2026, Setting a New Benchmark for Speed and Patient Access Designed to Support Diagnostic Confidence for Acute and High-demand Imaging Environments ...
Japan eats rice daily yet has just 3.6% obesity. Small portions, Hara Hachi Bu, soup-first meals, active living and minimal ...
Indian youth ranked 60th among 84 countries in Mind Health Quotient scores, while seniors ranked 49th in the Global Mind Health 2025 report.
Semaglutide's patent expiry in India could sharply reduce the cost of popular weight-loss and diabetes injections.
What is Inluryo, and who can benefit from it? Learn about this newly approved breast cancer treatment and how it works.
Using prime editing, NCF1 mutation is corrected in a 19-year-old with chronic granulomatous disease, an inherited immune disorder, marking a gene therapy milestone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results